TP53 Mutation
3 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| Maintenance Treatment With Bevacizumab and Atezolizumab for Ovarian Cancer (NCT04510584) | University Health Network, Toronto | 2021-07-16 |
| Sintilimab Plus R-CHOP as the First-line Treatment in Patients With Diffuse Large B-Cell Lymphoma. (NCT04023916) | Chinese Academy of Medical Sciences | 2019-12-01 |
Track TP53 Mutation automatically
Every clearance here is in the API, with alerts when new ones post.